With a market cap of $37.7 billion, Prudential Financial, Inc. (PRU) is a leading global financial services company founded in 1875. Operating across the U.S. and over 40 countries, the New Jersey-based company provides life insurance, annuities, retirement and wealth solutions, and asset management through its investment arm, PGIM, which manages about $1.5 trillion in assets.
Shares of the insurance provider have trailed the broader market over the past year and in 2025. PRU stock has declined 6.3% over the past 52 weeks and 9.6% on a YTD basis. In comparison, the S&P 500 Index ($SPX) has returned 13.3% over the past year and 8.3% in 2025.
Narrowing the focus, PRU has also lagged behind the iShares U.S. Insurance ETF’s (IAK) 8.6% rally over the past 52 weeks and its 5.3% surge this year.
On Jul. 30, Prudential Financial posted strong Q2 results, and its shares dipped 1.6%. Its adjusted operating income after tax rose to $3.58 per share from $3.28 a year earlier, driven by solid contributions from its asset management arm PGIM and international businesses. Assets under management climbed to $1.58 trillion from $1.48 trillion, underscoring growth momentum. The company also returned $735 million to shareholders through dividend payments and share repurchases.
For the current year ending in December, analysts expect PRU’s EPS to increase 8.1% year over year to $13.64. Moreover, the company has surpassed analysts’ consensus estimates in three of the past four quarters, while missing on one occasion.
Among the 18 analysts covering the stock, the consensus rating is a “Hold.” That’s based on two “Strong Buy” ratings, 14 “Holds,” and two “Strong Sells.”
On August 18, Morgan Stanley (MS) analyst Nigel Dally reaffirmed an "Equal-Weight" rating on Prudential Financial and raised the price target from $113 to $117, a 3.5% increase signaling a more positive near-term outlook.
PRU’s mean price target of $116.13 indicates a premium of 8.4% from the current market prices. Its Street-high target of $136 suggests a robust 26.9% upside potential from current price levels.
On the date of publication, Kritika Sarmah did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.